On Sale Affielisa® Mouse Vasoactive Intestinal Polypeptide Receptor 2 Elisa [ Vipr2] Price Crushed By 60% [K1if4TPp]

AffiELISA® Mouse Vasoactive intestinal polypeptide receptor 2 ELISA [Vipr2]

Introducing the AffiELISA® Mouse Vasoactive intestinal polypeptide receptor 2 ELISA [Vipr2], a state-of-the-art assay kit designed for researchers focused on studying the crucial role of the Vasoactive intestinal polypeptide receptor 2 (Vipr2) in various biological processes. This kit offers a reliable and sensitive solution for detecting and quantifying Vipr2 in mouse samples, ensuring accurate and reproducible results.

• High specificity: The AffiELISA® kit utilizes a unique antibody pair that guarantees high specificity for Vipr2, minimizing cross-reactivity with other proteins.
• Easy-to-use protocol: The kit comes with a straightforward, user-friendly protocol that can be easily adapted to your laboratory's workflow.

Product Specifications

The AffiELISA® Mouse Vipr2 ELISA kit is designed for in vitro quantitative determination of mouse Vipr2 in cell culture supernatants, plasma, serum, and urine. Key features of the kit include:

• Assay format: 96-well strip plate
• Assay range: 0.78 to 50 pg/ml
• Detection limit: 0.16 pg/ml
• Interference-free: The kit is designed to minimize interference from commonly encountered substances, ensuring accurate results.

Applications and Benefits

The AffiELISA® Mouse Vipr2 ELISA kit is an invaluable tool for researchers investigating the functions of Vipr2 in various physiological and pathological conditions. Its applications include:

• Neuroscience research: Studying the role of Vipr2 in neurotransmission and pain pathways.
• Endocrinology: Investigating the involvement of Vipr2 in hormonal regulation and metabolism.
• Pharmacology: Assessing the effects of Vipr2 antagonists and agonists in drug discovery and development.

With its exceptional sensitivity, specificity, and user-friendly design, the AffiELISA® Mouse Vipr2 ELISA kit is the ideal choice for your Vipr2 research needs.